Artelo Biosciences (ARTL) Return on Assets (2015 - 2025)
Artelo Biosciences (ARTL) posted quarterly Return on Assets of 0.03% for Q4 2025, down 1.0% year-over-year from 0.03% in Q4 2024, and up 21.8% quarter-over-quarter from 0.04% in Q3 2025.
Artelo Biosciences (ARTL) Return on Assets (2015 - 2025) Analysis & Trends
Artelo Biosciences (ARTL) has reported Return on Assets for 11 consecutive years, with 0.03% the latest figure, recorded in Q4 2025.
- In Q4 2025, Return on Assets fell 1.0% year-over-year to 0.03%; the TTM figure through Dec 2025 stood at 0.03% (down 1.0% YoY), while the FY2025 annual figure was 0.05%, down 3.0% from the prior year.
- Return on Assets improved to 0.03% in Q4 2025 per ARTL's latest filing, from 0.04% in the prior quarter.
- Across five years, Return on Assets topped out at 0.0% in Q1 2022 and bottomed at 0.04% in Q3 2025.
- Historically, Return on Assets has averaged 0.01% across 5 years, with a median of 0.01% in 2023.
- Annual changes were most pronounced in 2021 — Return on Assets rose 1 bps — and 2025, when it declined 3 bps.
- Artelo Biosciences' Return on Assets stood at 0.01% in 2021, then climbed by 6 bps to 0.0% in 2022, then tumbled by 46 bps to 0.01% in 2023, then slumped by 282 bps to 0.03% in 2024, then fell by 27 bps to 0.03% in 2025.
- Business Quant data shows ARTL's Return on Assets at 0.03% in Q4 2025, 0.04% in Q3 2025, and 0.04% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.00% |
| 10 | Artelo Biosciences | 107,735.40 | -492,264.60 | - | -0.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.03% |
| Sep 30, 2025 | -0.04% |
| Jun 30, 2025 | -0.04% |
| Mar 31, 2025 | -0.04% |
| Dec 31, 2024 | -0.03% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | -0.01% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | -0.01% |
| Sep 30, 2023 | -0.01% |
| Jun 30, 2023 | -0.01% |
| Mar 31, 2023 | -0.01% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Nov 30, 2021 | -0.01% |
| Aug 31, 2021 | -0.01% |
| May 31, 2021 | 0.00% |
| Feb 28, 2021 | 0.00% |